New diabetes clinical trial: Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets

Published on: 2026-04-06T04:00:00Z
Conditions: T2DM (Type 2 Diabetes Mellitus)
Interventions: Drug: Chiglitazar/Metformin extended-release tablets under fasting conditions; Drug: Chiglitazar/Metformin extended-release tablets after a high-fat meal; Drug: multiple-dose of Chiglitazar/Metformin extended-release tablets
Sponsors: Chipscreen Biosciences, Ltd.
Not yet recruiting
https://ift.tt/XIhY5Py